Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

The oncologist·2026
Same author

Front-line chemo-immunotherapy for advanced penile cancer: ready for prime time?

British journal of cancer·2026
Same author

Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy.

Scientific reports·2025
Same author

Skull Base Osteomyelitis- Microbiological Profile and Management Implications.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2025
Same author

Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched Analysis.

JCO global oncology·2025
Same author

Metastatic Malignant Pseudomyogenic Hemangioendothelioma: An Exceedingly Rare Entity That Challenges Conventional Paradigms.

International journal of surgical pathology·2024
Same journal

Severe combined immunodeficiency (SCID) with pigmentary mosaicism: A coincidental occurrence in a child.

Indian journal of dermatology, venereology and leprology·2026
Same journal

Agminated multifocal eruptive lobular capillary haemangiomas - An uncommon presentation.

Indian journal of dermatology, venereology and leprology·2026
Same journal

Patch testing in India: Are we missing clinically relevant allergens?

Indian journal of dermatology, venereology and leprology·2026
Same journal

Double-loading technique for improved suspension retention on the recipient site in non-cultured epidermal cell suspension (NCES).

Indian journal of dermatology, venereology and leprology·2026
Same journal

Late-onset metastatic melanoma arising from a medium-sized congenital melanocytic naevus.

Indian journal of dermatology, venereology and leprology·2026
Same journal

Custom-compounded glycine-proline jelly for ulcers in prolidase deficiency.

Indian journal of dermatology, venereology and leprology·2026
See all related articles

Related Experiment Video

Updated: Feb 9, 2026

Nitroreductase/Metronidazole-Mediated Ablation and a MATLAB Platform RpEGEN for Studying Regeneration of the Zebrafish Retinal Pigment Epithelium
13:12

Nitroreductase/Metronidazole-Mediated Ablation and a MATLAB Platform RpEGEN for Studying Regeneration of the Zebrafish Retinal Pigment Epithelium

Published on: March 2, 2022

2.9K

Metronidazole in Scabies.

V M Mathew, Zachariah Thomas

    Indian Journal of Dermatology, Venereology and Leprology
    |March 8, 2017
    PubMed
    Summary
    This summary is machine-generated.

    This study evaluated oral metronidazole for scabies treatment. While 27% of patients showed good to excellent results, 36% had a fair response, and 36% saw no improvement, indicating limited efficacy for this parasitic skin infection.

    More Related Videos

    Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
    07:20

    Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium

    Published on: April 9, 2019

    9.8K
    A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
    12:58

    A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

    Published on: May 25, 2017

    9.4K

    Related Experiment Videos

    Last Updated: Feb 9, 2026

    Nitroreductase/Metronidazole-Mediated Ablation and a MATLAB Platform RpEGEN for Studying Regeneration of the Zebrafish Retinal Pigment Epithelium
    13:12

    Nitroreductase/Metronidazole-Mediated Ablation and a MATLAB Platform RpEGEN for Studying Regeneration of the Zebrafish Retinal Pigment Epithelium

    Published on: March 2, 2022

    2.9K
    Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
    07:20

    Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium

    Published on: April 9, 2019

    9.8K
    A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
    12:58

    A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

    Published on: May 25, 2017

    9.4K

    Area of Science:

    • Dermatology
    • Parasitology
    • Pharmacology

    Background:

    • Scabies is a contagious parasitic infestation caused by the mite Sarcoptes scabiei.
    • Effective treatment options for scabies are crucial due to its high transmissibility and potential for secondary infections.

    Purpose of the Study:

    • To evaluate the efficacy of oral metronidazole as a therapeutic agent for scabies.
    • To determine the response rates of scabies patients treated with a specific metronidazole dosage regimen.

    Main Methods:

    • A study involving twenty-five patients diagnosed with scabies.
    • Patients received oral metronidazole at a dosage of 400 mg three times daily for 8 consecutive days.
    • Treatment outcomes were categorized into good to excellent, fair, and no response.

    Main Results:

    • Good to excellent therapeutic response was observed in 6 out of 25 patients (27.27%).
    • A fair response was noted in 8 patients (36.36%).
    • No significant clinical improvement or response was observed in the remaining 8 patients (36.36%).

    Conclusions:

    • Oral metronidazole at the tested dosage showed limited efficacy in treating scabies.
    • A substantial proportion of patients did not achieve a satisfactory therapeutic outcome.
    • Further research may be needed to explore alternative or combination therapies for scabies.